MCK
McKesson Corporation
NYSE: MCK · HEALTHCARE · MEDICAL DISTRIBUTION
$815.20
-0.90% today
Updated 2026-04-30
Market cap
$99.85B
P/E ratio
23.53
P/S ratio
0.25x
EPS (TTM)
$34.65
Dividend yield
0.37%
52W range
$635 – $999
Volume
0.8M
McKesson Corporation (MCK) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+4.6%
Last 4 quarters
Revenue YoY growth
+11.4%
Most recent quarter
EPS YoY growth
+16.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+2.7%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+12.5%
2026-02-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-04 | $9.34 | +2.0% | $851.12 | $957.80 | +12.5% |
| 2025-11-05 | $9.86 | +12.2% | $841.67 | $858.61 | +2.0% |
| 2025-08-06 | $8.26 | +1.3% | $709.49 | $663.25 | -6.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $9.16 | $9.34 | +2.0% | $106.16B | +11.4% |
| 2025-09-30 | $8.79 | $9.86 | +12.2% | $103.15B | +10.1% |
| 2025-06-30 | $8.15 | $8.26 | +1.3% | $97.83B | +23.4% |
| 2025-03-31 | $9.83 | $10.12 | +3.0% | $90.82B | +18.9% |
| 2024-12-31 | $7.99 | $8.03 | +0.5% | $95.29B | +17.8% |
| 2024-09-30 | $6.87 | $7.07 | +2.9% | $93.65B | +21.3% |
| 2024-06-30 | $7.21 | $7.88 | +9.3% | $79.28B | +6.4% |
| 2024-03-31 | $6.34 | $6.18 | -2.5% | $76.36B | — |
| 2023-12-31 | $7.05 | $7.74 | +9.8% | $80.90B | — |
| 2023-09-30 | $6.15 | $6.23 | +1.3% | $77.22B | — |
| 2023-06-30 | $5.87 | $7.27 | +23.9% | $74.48B | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $39.41 | $412.8B | +8.2% | 13 | high |
| 2027 (E) | $44.69 | $446.6B | +8.2% | 13 | high |
| 2028 (E) | $50.50 | $483.0B | +8.1% | 13 | medium |
| 2029 (E) | $57.00 | $522.0B | +8.1% | 13 | medium |
| 2030 (E) | $64.10 | $564.0B | +8.0% | 13 | medium |
Frequently asked questions
Has McKesson Corporation beaten earnings estimates?
McKesson Corporation has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +4.6% over the last 4 quarters.
How does MCK stock react to earnings?
MCK stock has moved an average of +2.7% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is McKesson Corporation's revenue growth rate?
McKesson Corporation reported year-over-year revenue growth of +11.4% in its most recent quarter, with EPS growing +16.3% year-over-year.
What is the expected EPS for MCK in 2026?
Analysts expect McKesson Corporation to report EPS of $39.41 for fiscal year 2026, on revenue of $412.8B, based on estimates from 13 analysts.